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Ilya Metchnikoff is widely hailed as the father of modern immu-
nology based on his prescient characterization in the late 19th
Century of the macrophage’s roles in phagocytic clearance of
infections, tissue development and wound repair [1]. In the ensu-
ing 120 years, his paradigm of macrophage function has
remained largely intact, albeit with a greater appreciation for
their functional complexity. In addition to those classical func-
tions identiﬁed by Metchnikoff, macrophages can also regulate
hematopoiesis, reproduction, vasoregulation, apoptosis, cancer
metastasis and lipid metabolism [1,2]. Moreover, there is a grow-
ing understanding of macrophage specialization, with their clas-
siﬁcation into two major subtypes, M1 and M2, which are
distinguished primarily by the type of inﬂammation they elicit.
M1 macrophages drive Th1 lymphocyte responses characterized
by secretion of interleukin-1, interleukin-6 and tumor necrosis
factor alpha, whereas M2 macrophages primarily drive allergic
responses with killing and encapsulation of parasites typical of
Th2 responses, with secretion of interleukin-4 and interleukin-
13 [3]. In reality, there is a continuum of macrophage phenotypes
between these two ends of the spectrum, featuring evolving pat-
terns of secretion of interleukins, chemokines, reactive oxygen
species, and expression of membrane receptors [3]. Indeed, ﬂow
cytometry can be used to characterize and isolate macrophage
subtypes based on their cell surface receptor expression [4]. Mac-
rophage heterogeneity can also be tracked by their patterns of
transcriptional regulation, with sequence-speciﬁc transcription
factors and epigenetic changes driving macrophage identity and
polarization [5].
Two liver diseases where macrophage polarization is espe-
cially pertinent are hepatic ﬁbrosis and fatty liver disease. A sem-
inal study in 2005 demonstrated divergent roles of macrophages
in experimental liver ﬁbrosis, in which their depletion during
ﬁbrosis progression attenuated ﬁbrosis, whereas their depletion
during ﬁbrosis regression made ﬁbrosis worse [6]. With a clearer
appreciation for the polarity of macrophages, it is increasingly
likely that these opposing roles of macrophages are accounted
for by different subpopulations within the liver [4], as well as
by the contribution of related innate immune cells, especially
dendritic cells [7]. Similarly, in non-alcoholic fatty liver disease
(NAFLD), there is altered composition of macrophages, with an
increase in M1 cytokines and Th1 lymphocytes in both liver [8]Journal of Hepatology 20
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inﬂammatory signaling converge with those controlling lipid
metabolism to explain how fat alterations may modulate inﬂam-
mation [10,11].
The paper by Leroux et al. in this issue of the Journal, adds to
the mounting evidence that hepatic fat accumulation alters mac-
rophage biology, which contributes to NAFLD pathogenesis asso-
ciated with the metabolic syndrome. In this study, hepatic
macrophages (Kupffer cells) were characterized in normal mice
fed a high-fat diet for 16 weeks, and in congenitally obese ob/ob
mice, which lack leptin. Cells were analyzed by ﬂow cytometry,
lipid content, gene expression and their ability to recruit lympho-
cytes. Interestingly, total Kupffer cell numbers were not affected,
yet functional changes in the cells from fatty livers were signiﬁ-
cant. Speciﬁcally, there were enlarged lipid droplets with
increased levels of diacylglycerols and ceramides, the latter of
which are associated with increased apoptosis and stimulation
of macrophage activation in the metabolic syndrome [12]. There
was also induction of lipogenic and inﬂammatory gene expres-
sion (IL-6, IL1b and CXCL10) in Kupffer cells from fatty livers,
which could be attenuated by inhibiting acetyl-CoA carboxylase,
the ﬁrst step in lipogenesis. Moreover, Kupffer cells from fatty liv-
ers were more sensitive to LPS stimulation, with enhanced
recruitment of CD45+, CD4+ and CD8+ lymphocytes into the liver.
Together, these data further implicate macrophages in the
inﬂammation associated with hepatic fat accumulation. They also
highlight the interesting question of how intracellular lipid alter-
ations contribute to hepatic macrophage polarization, an issue
not fully explored in prior studies. Above all, the ﬁndings clearly
demonstrate that it is a phenotypic polarization of macrophages
rather than a change in cell number that accounts for their con-
tribution to inﬂammation in fatty liver.
What are the translational implications of these ﬁndings? One
day it may be possible to therapeutically enhance macrophage
plasticity through several approaches. First, the knowledge of epi-
genetic regulation of macrophage phenotype has led to selective
interference of inﬂammation by altering chromatin-dependent
gene regulation [13]. Second, a recent study has demonstrated
that soluble amyloid P protein, a circulating pattern recognition
molecule, alters macrophage phenotype to facilitate clearance of
debris and suppress pro-inﬂammatory gene expression thereby
reducing experimental ﬁbrosis [14]. Finally, there is the prospect
of ex vivo manipulation and expansion following isolation of
endogenousmacrophage populations in order to deliver therapeu-
tic cell populations that reduce inﬂammation and alter disease.
While these approaches are not likely to alter the outcome of12 vol. 57 j 1–2
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the chronic systemic disease of metabolic syndrome with NAFLD
in the in the near term, the clariﬁcation of howmacrophages con-
tribute to its pathogenesis allows us to deﬁne diagnostic and ther-
apeutic targets for the future, a prospect that owes its origins to
the work of a 19th Century immunologist.Conﬂict of interest
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